A Detailed Evaluation of the Effect of Prostate-specific Antigen-based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer.

de Vos, Ivo I; Meertens, Annick; Hogenhout, Renée; Remmers, Sebastiaan; Roobol, Monique J

de Vos, Ivo I; Meertens, Annick; Hogenhout, Renée; Remmers, Sebastiaan; Roobol, Monique J.

Afiliação

de Vos II; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic address: i.devos@erasmusmc.nl.
Meertens A; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Hogenhout R; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Remmers S; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Roobol MJ; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Eur Urol ; 84(4): 426-434, 2023 10.

Article em En | MEDLINE | ID: mdl-37029074

Assuntos

Antígeno Prostático Específico; Neoplasias da Próstata; Humanos; Masculino; Detecção Precoce de Câncer/métodos; Seguimentos; Programas de Rastreamento/métodos; Morbidade; Neoplasias da Próstata/mortalidade

Palavras-chave

Mortality; Neoplasm metastases; Prostate-specific antigen; Prostatic neoplasms; Screening

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google